Kogan Elona has filed 7 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 10000 shares of Apimeds Pharmaceuticals US, Inc. ($APUS) on November 11, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 11, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Kogan Elona | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 12,575,983 | 9999.99% | 0.08% |
| Oct. 15, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Kogan Elona | Director | A | Stock Option (right to buy) | 3000 | $0.00 | 3,000.0000 | 12,575,983 | 9999.99% | 0.02% |
| May 16, 2025 | Apimeds Pharmaceuticals US, Inc. | $APUS | Kogan Elona | Director | A | Stock Option (right to buy) | 5780 | $0.00 | 5,780.0000 | 7,903,850 | 9999.99% | 0.07% |
| Feb. 6, 2024 | Seer, Inc. | $SEER | Kogan Elona | CHIEF LEGAL OFFICER | A | Class A Common Stock | 123153 | $0.00 | 285,826.0000 | 64,298,676 | 75.71% | 0.19% |
| Feb. 6, 2024 | Seer, Inc. | $SEER | Kogan Elona | CHIEF LEGAL OFFICER | A | Employee Stock Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 64,298,676 | 9999.99% | 0.22% |
| Feb. 22, 2024 | Seer, Inc. | $SEER | Kogan Elona | CHIEF LEGAL OFFICER | S | Class A Common Stock | 12684 | $1.58 | 273,142.0000 | 64,298,676 | 4.44% | 0.02% |
| Feb. 6, 2024 | Seer, Inc. | $SEER | Kogan Elona | CHIEF LEGAL OFFICER | A | Employee Stock Option (right to buy) | 79729 | $0.00 | 79,729.0000 | 64,298,676 | 9999.99% | 0.12% |